This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

Stay connected with NSH and renew today!
NSH
Don't forget to renew your membership with NSH and enjoy all of the great benefits including discounts to NSH events, textbooks and educational materials, free webinars, continuing education credits and much more. Not a past member? Join the NSH family today and share your histology experiences with other professionals around the country. Learn more.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




TOP STORIES


EMA seeks feedback on clinical trial database
Regulatory Affairs Professionals Society
In 2014, the European Medicines Agency made headlines when it announced it would require pharmaceutical companies to report the results of their clinical trials. Now, in a new notice, EMA is asking for help in determining how it should make that information available to the public, including how it should balance transparency with confidentiality.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Human stem cells could one day be regulated to replace aged, damaged and missing tissues
Medical Xpress
When a salamander loses a tail, it grows a new one. What's the difference, MIT biologist Peter Reddien, Ph.D., wondered, between a wound that severs a salamander's tail and one that severs a human spinal cord? Tweaking a gene or injecting a drug to repair damaged or aging organs, muscles, nerves or brain tissue is one of the most enticing medical scenarios imaginable — a scenario that Reddien, an associate professor and associate department head of biology and a Howard Hughes Medical Institute investigator, hopes will one day make the leap from fiction to science.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  GBI Cost Effective Products

GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species. We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.
 


Good news for clinical lab scientists: iPad app for medical lab pipetting protects lives and jobs
Dark Daily
Even something as mundane as pipetting is getting a high-tech makeover and clinical laboratory scientists around the world are likely to benefit from an innovation that incorporates an iPad into the pipetting process. Scientists at the prestigious Cambridge, Massachusetts-based Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology recently unveiled the iPipet system. This in an innovative system which employs tablet computers such as iPads to guide the tedious and often dangerous task of manual pipetting, according to a news release.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Miss an issue of Under The Microscope? Click here to visit the Under The Microscope archive page.


Zombie bacteria in tuberculosis
Bioscience Technology
Tuberculosis affects more than 12 million people globally and is usually treated with a course of four drugs over several months. However, even after completing the treatment, many patients suffer relapses. Based on studies of harmless environmental bacteria, scientists think that the tuberculosis bacterium, Mycobacterium tuberculosis, retreats into a bizarre "zombie" state in the patient's body and comes back to life when the conditions permit.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




IN THE NEWS


Using stem cells to grow new hair
Sanford-Burnham Medical Research Institute via Medical Xpress
In a new study from Sanford-Burnham Medical Research Institute, researchers have used human pluripotent stem cells to generate new hair. The study represents the first step toward the development of a cell-based treatment for people with hair loss. In the United States alone, more than 40 million men and 21 million women are affected by hair loss. The research was published online in PLOS One recently.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Baptist Health School of Histotechnology

The Baptist Health School of Histotechnology has an one-year online program that may be the program for you! A non-residential student must have access to an accredited Histology lab and completed 1080 hours of Histology lab experience prior to starting the program. Classes begin in July each year, so call today!
 


Breakthrough DNA editing tool may help pathologists develop new diagnostic approaches to identify, treat underlying causes of diseases at genetic level
Dark Daily
In just 24 months, a new gene-editing tool has become the hot topic worldwide among researchers working to understand DNA and develop ways to manipulate it for therapeutic purposes. It goes by the acronym CRISPR and it may soon become quite familiar to most pathologists and medical laboratory scientists. CRISPR stands for clustered regularly interspaced short palindromic repeats. The gene editing platform is known as CRISPR/CAS9.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword DNA.


Does virus diversity drive bowel diseases?
Futurity
In addition to less diversity of bacteria in the gut, inflammatory bowel diseases are also associated with a greater diversity of viruses, report researchers. A new study finds that patients with inflammatory bowel diseases had a greater variety of viruses in their digestive systems than did healthy volunteers, which suggests that viruses likely play a role in the diseases.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Hassle Free Block Storage Cabinet

Avantik Biogroup is proud to introduce another Customer Requested Quality Innovation for Histology...the Avantik Biogroup Block Storage Cabinet! We introduced Hassle-Free Drawer Technology with Interlocking Stackability and More Clearance between the top of the blocks and the drawers to achieve the industry's first Jam-Free, Hassle-Free Block Storage Cabinet!
 


Thymic carcinoma recurrence can be determined with existing uterine cervix pathology test
Oncology Nurse Advisor
Partnering with head and neck surgeons, pathologists developed a new use for an old test to determine if a patient's cancer is recurrent, or if the biopsy shows benign inflammation of mucosal tissues. The research team, led by Candice C. Black, DO, of Dartmouth Hitchcock Medical Center's Norris Cotton Cancer Center in Lebanon, New Hampshire, confirmed the utility of ProExC, an existing antibody cocktail commonly used for pathology tests of the uterine cervix.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Being a 'guinea pig' in a clinical trial
ABC Health & Wellbeing
Sixty years ago, childhood leukaemia was a uniformly fatal illness. With nothing in the medical arsenal to treat the disease, it killed just about every child who developed it. If a child is diagnosed with leukaemia today, they have around an 80 percent of surviving beyond five years. This means that four out of five of these children will still be alive after five years. It's an extraordinary medical achievement, and one that owes much to the fact that in the past, a large proportion of sufferers have taken part in clinical trials of new treatments.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    The Scientist's 'Top 10 Innovations' for 2014 offer powerful new research tools to advance diagnostics and possibly find uses in clinical labs (Dark Daily)
US lawmakers pass 'Ensuring Access to Clinical Trials Act of 2015' for rare disease research (Cystic Fibrosis News Today)
NSH webinar: Microwave Staining of Microorganisms (NSH)
Science at risk as young researchers increasingly denied research grants (Lab Manager)
Researchers open 'Pandora's box' of potential cancer biomarkers (Medical Xpress)

Don't be left behind. Click here to see what else you missed.


 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Jan. 21, 2015
Jan. 14, 2015
Jan. 7, 2015
Dec. 31, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063